Crohn’s Disease Market- Current Impact to Make Big Changes by 2035
This report presents a detailed, data-driven analysis of the global Crohn’s Disease MarketSize, Share, Trends, Industry Analysis Report size, offering insights into historical performance, current dynamics, and projections from 2025 to 2035. With a strong emphasis on factual assessment, the report refrains from speculative assumptions and aims to support business decisions through accurate forecasting and strategic intelligence.

I recently came across a report by Roots Analysis that really put things into perspective. According to them, The global Crohn's disease market size, valued at USD 9.6 billion in 2025, is projected to reach USD 10.3 billion in 2026 and USD 18.1 billion by 2035, representing a CAGR of 6.5% during the forecast period 2026 to 2035.

Read More: https://www.rootsanalysis.com/....reports/crohns-disea

Dental Tourism Market- Current Impact to Make Big Changes by 2035
This report presents a detailed, data-driven analysis of the global Dental Tourism Market size, offering insights into historical performance, current dynamics, and projections from 2025 to 2035. With a strong emphasis on factual assessment, the report refrains from speculative assumptions and aims to support business decisions through accurate forecasting and strategic intelligence.
I recently came across a report by Roots Analysis that really put things into perspective. According to them, The global dental tourism market size is estimated to grow from USD 10.36 billion in 2025 to USD 41.49 billion by 2035, representing a higher CAGR of 14.9% during the forecast period.
Read More: https://www.rootsanalysis.com/....reports/dental-touri

Antiviral Drugs Market Growth and Status Explored in a New Research Report 2035
The newly published market report titled Antiviral Drugs Market analysis offers a robust, data-centric perspective on how the Antiviral Drugs industry has evolved and where it is headed through 2035. Built on credible, verified insights, the study delivers a structured review of market size, geographic expansion, and strategic behavior across stakeholders.

I recently came across a report by Roots Analysis that really put things into perspective. According to them, The global antiviral drugs market size is estimated to grow from USD 69 billion in 2025 to reach USD 74 billion in 2026 and USD 127 billion by 2035, representing a higher CAGR of 6.1% during the forecast period 2026 to 2035.

The research highlights general factors that may be contributing to market expansion, offering a neutral and data-focused view. The Antiviral Drugs Market forecast is based on the analysis of available information, without assigning speculative cause-and-effect reasoning to specific trends.

Read More: https://www.rootsanalysis.com/....reports/antiviral-dr

Report Highlights

Key Questions Answered

- Question 1: What are antiviral drugs?
- Question 2: What is the antiviral drugs market size?
- Question 3: What is the projected market growth of the antiviral drugs?
- Question 4: Who are the leading companies in the antiviral drugs market?
- Question 5: Which region is the hub for antiviral drug developers?
- Question 6: Which type of formulation is most preferred for antiviral drugs?
- Question 7: What are the investment trends in antiviral drug development?
- Question 8: How do antiviral drugs work?

- Historical Trend: Since 2018
- Forecast Period: Till 2035
- Market Size in 2026: USD 74 Billion
- Market Size in 2035: USD 127 Billion
- CAGR (Till 2035): 6.1%
- By Mechanism ofAction
• Fusion Inhibitors
• DNA Polymerases
• Protease Inhibitors
• Reverse Transcriptase
• Others
- By Target Indication
• Human Immunodeficiency Virus Infection
• Coronavirus Infection
• Hepatitis
• Herpes Simplex Virus Infection
• Cytomegalovirus Infection
• Influenza
• Others
- By Drug Target
• Virus Targets
• Host Targets
- By Type of Therapy
• Monotherapy
• Combination Therapy
- Key GeographicalRegions
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and North Africa
- Key Companies Profiled
• AbbVie
• AstraZeneca
• Bristol-Myers Squibb
• Genentech
• Gilead Sciences
• GlaxoSmithKline (GSK)
• Johnson & Johnson
• Merck
• Novartis
• Pfizer
• Roche
• ViiV Healthcare
- PowerPoint Presentation(Complimentary): Available
- Customizaiton Scope: 15% Free Customization
- Excel Data Packs(Complimentary)
• Market Landscape Analysis for Approved Antiviral Drugs
• Market Landscape Analysis for Clinical Antiviral Drugs
• Funding and Investment
• Partnership and Collaboration Analysis
• Market Forecast and Opportunity Analysis

Medical Wearables Market Extensive Industry Analysis

Roots Analysis recently published a report on the global Wearable Medical Devices Market growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories.

Market Size and Forecast

Current Market Size: $39.31 Billion

Future Market Size: $232.98 Billion

CAGR: 19.48%

Market Overview

This growth is calculated based on observed trends, actual industry performance, and current developments in product usage and adoption. The study takes into account the challenges faced by key players and the general market structure, while avoiding speculative interpretations. It focuses on providing a clear picture of market performance across different regions and segments.

This report supports strategic planning by delivering verified data, cross-segment comparisons, and actionable insights—available in both PDF and spreadsheet formats for ease of integration.

Reference: https://www.rootsanalysis.com/....reports/wearable-med

Digital Psychotherapeutics Market Extensive Industry Analysis
Roots Analysis recently published a report on the global Digital Psychotherapeutics Market growth. With a focus on historical trends, current developments, and future projections, it offers a data-rich foundation for decision-makers, industry participants, and investors. The report includes both macro and micro-level insights, enabling readers to grasp key dynamics across segments, regions, and product categories.

Market Size and Forecast

Current Market Size:USD 2.41 billion

Future Market Size: USD 25.71 billion

CAGR: 28.2%

Market Overview

This growth is calculated based on observed trends, actual industry performance, and current developments in product usage and adoption. The study takes into account the challenges faced by key players and the general market structure, while avoiding speculative interpretations. It focuses on providing a clear picture of market performance across different regions and segments.

This report supports strategic planning by delivering verified data, cross-segment comparisons, and actionable insights—available in both PDF and spreadsheet formats for ease of integration.

Reference: https://www.rootsanalysis.com/....reports/digital-psyc

Market Scope and Segmentation

- Historical Trend: Since 2019
- Forecast Period: Till 2035
- Market Size in 2035: USD 25.71 billion
- CAGR: 28.2%
- Type of Solution
• Monotherapy
• Combination Therapy
- Type of Application
• Preventative
• Management
• Treatment
- Type of Indication
• Phobias and Anxiety
• Psychotic Disorders
- Type of Business Model
• Direct to Patients
• B2B
- Key Geographical Regions
• North America (
• Europe (
• Asia-Pacific (
• Middle East and North Africa
• Latin America
- Key Companies Profiled
• 2MORROW
• Canary Health
• Dthera Sciences
• Fitbit Health Solutions
• Livongo Health
• Medtronic
• Mango Health
• Noom
• Omada Health
• Pear Therapeutics
• Resmed (
• Voluntis
• Welldoc
- PowerPoint Presentation(Complimentary): Available
- Customization Scope: 15% Free Customization
- Excel Data Packs(Complimentary): Available